• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】10926

【品名】(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium

【CA登记号】

【 分 子 式 】C8H4KNO2

【 分 子 量 】185.2236

【元素组成】C 51.88% H 2.18% K 21.11% N 7.56% O 17.28%

与该中间体有关的原料药合成路线共 16 条

合成路线1

该中间体在本合成路线中的序号:(XI)

2) Hexadeuteroethyl alcohol (IX) is treated with red phosphorus and I2 at reflux temperature to give pentadeuteroethyl iodide (X), which is condensed with potassium phthalimide (XI) in DMF, yielding N-(pentadeuteroethyl)phthalimide (XII). The hydrolysis of (XII) with hydrazine and HCl affords pentadeuteroethylamine (XIII), which is condensed with 1-methylpiperidin-4-one (III) and formaldehyde (XIV) in a Mannich reaction to give 3-methyl-7-(pentadeuteroethyl)-3,7-diazabicyclo[3.3.1]nonan-9-one (XV). The reduction of (XV) with NaBH4 as before yields the diastereomeric mixture (XVI + XVII). Finally, the alpha-isomer (XVI) is condensed with 4-chlorobenzoyl chloride (VIII) as before to give the pentadeuterium-labeled bisaramil.

1 Mlinko, S.; Simon Trompler, E.; Szammer, J.; Synthesis of bisaramil labelled with carbon-14 and deuterium. J Label Compd Radiopharm 1994, 34, 4, 313.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 10919 1-Methyl-4-piperidone; 1-Methyltetrahydro-4(1H)-pyridinone; N-Methyl-4-piperidone;1-methylpiperidin-4-one 1445-73-4 C6H11NO 详情 详情
(VIII) 10295 p-Chlorobenzoyl chloride; 4-Chlorobenzoyl chloride 122-01-0 C7H4Cl2O 详情 详情
(IX) 10924 Ethyl alcohol; Ethanol 1516-08-1 C2H6O 详情 详情
(IX) 44687 Ethanol-d6 C2H6O 详情 详情
(X) 10925 Iodoethane;ethyl iod 75-03-6 C2H5I 详情 详情
(X) 44688 1-iodoethane-d5 C2H5I 详情 详情
(XI) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(XII) 10927 2-Ethyl-1H-isoindole-1,3(2H)-dione 5022-29-7 C10H9NO2 详情 详情
(XII) 44689 2-ethyl-1H-isoindole-1,3(2H)-dione C10H9NO2 详情 详情
(XIII) 10928 Ethanamine 75-04-7 C2H7N 详情 详情
(XIII) 44690 ethylamine; 1-ethanamine C2H7N 详情 详情
(XV) 10929 3-Ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-one C10H18N2O 详情 详情
(XV) 44691 3-ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-one C10H18N2O 详情 详情
(XVI) 10921 3-Ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-ol C10H20N2O 详情 详情
(XVI) 44692 3-ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-ol C10H20N2O 详情 详情
(XVII) 10922 3-Ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-ol C10H20N2O 详情 详情
(XVII) 44693 3-ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-ol C10H20N2O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(III)

1) The mesylation of 5'-O-tritylthymidine with mesyl chloride gives the corresponding 3'-O-mesyl derivative (II), which is cyclized by means of potassium phthalimide (III) in hot DMF water, yielding 5'-O-trityl-2,3'-anhydrothymidine (IV). The reaction of (IV) with sodium azide in refluxing DMF - water affords 5'-O-trityl-3'-azido-3'-deoxy thymidine (V), which is finally deprotected with 80% aqueous acetic acid at 100 C.

1 Glinski, R.P.; et al.; Nucleotide synthesis. IV. Phosphorylated 3'-amino-3'-deoxythymidine and 5'-amino-5'-deoxythymidine and derivatives. J Org Chem 1973, 38, 25, 4299.
2 Castaner, J.; Prous, J.; BW-A 509 U. Drugs Fut 1986, 11, 12, 1017.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12166 1-[(2R,4S,5R)-4-Hydroxy-5-[(trityloxy)methyl]tetrahydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione C29H28N2O5 详情 详情
(II) 12196 (2R,3S,5R)-5-[5-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2-[(trityloxy)methyl]tetrahydro-3-furanyl methanesulfonate C30H30N2O7S 详情 详情
(III) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(IV) 12168 (1R,9R,10R)-4-Methyl-10-[(trityloxy)methyl]-8,11-dioxa-2,6-diazatricyclo[7.2.1.0(2,7)]dodeca-3,6-dien-5-one C29H26N2O4 详情 详情
(V) 24469 1-[4-azido-5-[(trityloxy)methyl]tetrahydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione C29H27N5O4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

A new synthesis for Y-26611 has been reported: The reaction of 4-benzyl-2-(chloromethyl)morpholine (I) with potassium phthalimide (II) in refluxing DMF gives 4-benzyl-2-(phthalimidomethyl)morpholine (III), which is treated with hydrazine hydrate in refluxing ethanol yielding 2-(aminomethyl)-4-benzylmorpholine (IV). The acetylation of (IV) with acetic anhydride in cool toluene affords 2-(acetamidomethyl)-4-benzylmorpholine (V), which is debenzylated by hydrogenation with hydrazine hydrate over Pd/C in isopropanol to give 2-(acetamidomethyl)morpholine (VI). The condensation of (VI) with 1-cyclopropyl-6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (VII) by means of triethylamine in refluxing acetonitrile yields 7-[2-(acetamidomethyl)morpholin-4-yl]-1-cyclopropyl-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (VIII), which is finally deacetylated with refluxing aqueous HCl.

1 Hirayama, F.; Yokoyama, Y.; Moriguchi, A.; Ikeda, Y.; Araki, K.; Iwao, E.; Uemori, S.; Yakushiji, T.; Kuroda, T.; Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships. J Med Chem 1993, 36, 10, 1356.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13396 4-Benzyl-2-(chloromethyl)morpholine C12H16ClNO 详情 详情
(II) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(III) 13398 2-[(4-Benzyl-2-morpholinyl)methyl]-1H-isoindole-1,3(2H)-dione C20H20N2O3 详情 详情
(IV) 13399 (4-Benzyl-2-morpholinyl)methylamine; (4-Benzyl-2-morpholinyl)methanamine C12H18N2O 详情 详情
(V) 13400 N-[(4-Benzyl-2-morpholinyl)methyl]acetamide C14H20N2O2 详情 详情
(VI) 13401 N-(2-Morpholinylmethyl)acetamide C7H14N2O2 详情 详情
(VII) 13393 1-Cyclopropyl-6,7,8-trifluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid C13H8F3NO3 详情 详情
(VIII) 13403 7-[2-[(Acetamido)methyl]-4-morpholinyl]-1-cyclopropyl-6,8-difluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid C20H21F2N3O5 详情 详情

合成路线4

该中间体在本合成路线中的序号:(XII)

Reaction of 1,4-dibromopentane (XI) with potassium phthalimide (XII) gives N-(4-bromopentyl)phthalimide (XIII), which is then treated with NaI in refluxing acetone.

1 McIntyre, J.A.; Castaner, J.; Bayes, M.; Tafenoquine Succinate. Drugs Fut 2003, 28, 9, 859.
2 Ugwuegbulam, C.O.; Foy, J.E. (GlaxoSmithKline Inc.; GlaxoSmithKline plc); Process for the preparation of anti-malarial drugs. US 6479660; WO 9713753 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IX) 48082 2-(4-iodopentyl)-1H-isoindole-1,3(2H)-dione C13H14INO2 详情 详情
(XI) 57248 1,4-dibromopentane C5H10Br2 详情 详情
(XII) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(XIII) 57249 2-(4-bromopentyl)-1H-isoindole-1,3(2H)-dione C13H14BrNO2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VII)

The starting compound phthalimido derivative (I) could be obtained as follows: The condensation of 2-[2-(2-chloroethoxy)ethoxy]ethanol (VI) with potassium phthalimide (VII) in refluxing DMF gives the expected phthalimido derivative (VIII), which is oxidized with the Jones reagent in acetone yielding 2-[2-(2-phthalimidoethoxy)ethoxy]acetic acid (IX). The condensation of (IX) with 2,2-dimethyl-1,3-dioxane-4,6-dione (Meldrum's acid) (X) by means of carbonyldiimidazole (CDI) and pyridine in dichloromethane affords 2,2-dimethyl-5-[2-[2-(2-phthalimidoethoxy)ethoxy]acetyl]-1,3-dioxane-4,6-dione (XI), which is finally treated with refluxing ethanol to obtain the phthalimido derivative (I) used as starting material.

1 Crouzel, C.; Duval, R.; Hinnen, F.; Fuseau, C.; Dollé, F.; Valette, H.; Péglion, J.-L.; Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging. Bioorg Med Chem 1997, 5, 4, 749.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14743 ethyl 4-[2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]ethoxy]-3-oxobutanoate C18H21NO7 详情 详情
(VI) 14748 2-[2-(2-Chloroethoxy)ethoxy]-1-ethanol; 2-(2-(2-Chloroethoxy)ethoxy)ethanol 5197-62-6 C6H13ClO3 详情 详情
(VII) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(VIII) 14750 2-[2-[2-(2-Hydroxyethoxy)ethoxy]ethyl]-1H-isoindole-1,3(2H)-dione C14H17NO5 详情 详情
(IX) 14751 2-[2-[2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]ethoxy]acetic acid C14H15NO6 详情 详情
(X) 14738 Meldrum's acid; 2,2-dimethyl-1,3-dioxane-4,6-dione;Malonic acid cyclic isopropylidene ester 2033-24-1 C6H8O4 详情 详情
(XI) 14752 2-(2-[2-[2-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-2-oxoethoxy]ethoxy]ethyl)-1H-isoindole-1,3(2H)-dione C20H21NO9 详情 详情

合成路线6

该中间体在本合成路线中的序号:(II)

Substitution on dibromobutene (I) by potassium phthalimide (II) provided bromobutenyl phthalimide (III). Further treatment with sodium acetate afforded acetate (IV) which, after hydrolysis, gave phthalimidobutenol (V). Reaction with refluxing ethyl orthoacetate in the presence of a trace of butyric acid generated the intermediate ketene acetal (VI), which experienced a Claisen rearrangement to give pentenoate ester (VII). Ozonolysis of the olefinic double bond of (VII) yielded aldehyde (VIII). Then, Wittig reaction of aldehyde (VIII) with (isopropylidene)triphenylphosphorane in cold THF provided olefin (IX), which was hydrogenated in the presence of Pd/C to give the isobutyl compound (X). Finally, hydrolysis of both ester and phthalimide groups in refluxing 6 N HCl provided the GABA analogue.

1 Serfass, L.; Casara, P.J.; General synthesis of 3-substituted alkenyl GABA as potential anticonvulsants. Bioorg Med Chem Lett 1998, 8, 18, 2599.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18349 (E)-1,4-dibromo-2-butene;trans-1,4-dibromo-2-butene 821-06-7 C4H6Br2 详情 详情
(II) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(III) 18351 2-[(E)-4-bromo-2-butenyl]-1H-isoindole-1,3(2H)-dione C12H10BrNO2 详情 详情
(IV) 18352 (E)-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-butenyl acetate C14H13NO4 详情 详情
(V) 18353 2-[(E)-4-hydroxy-2-butenyl]-1H-isoindole-1,3(2H)-dione C12H11NO3 详情 详情
(VI) 18354 2-[(E)-4-[(1-ethoxyvinyl)oxy]-2-butenyl]-1H-isoindole-1,3(2H)-dione C16H17NO4 详情 详情
(VII) 18355 ethyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-4-pentenoate C16H17NO4 详情 详情
(VIII) 18356 ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-formylbutanoate C15H15NO5 详情 详情
(IX) 18357 ethyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-5-methyl-4-hexenoate C18H21NO4 详情 详情
(X) 18358 ethyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-5-methylhexanoate C18H23NO4 详情 详情

合成路线7

该中间体在本合成路线中的序号:(VIII)

A new synthesis of S-4661 has been reported: The esterification of trans-4-hydroxy-L-proline (I) with methanol/HCl gives the corresponding methyl ester (II), which is N-protected as trans-N-(4-methoxybenzyloxycarbonyl)-4-hydroxy-L-proline methyl ester (III). The mesylation of (III) with methanesulfonyl chloride and triethylamine in dichloromethane affords the 4-O-mesylate (IV), which is treated with sodium triphenylmethylsulfide giving cis-N-(4-methoxybenzyloxycarbonyl)-4-(triphenylmethylsulfanyl)-L-prolin e methyl ester (V). The reduction of (V) with LiBH4 in THF yields the corresponding methanol (VI), which is mesylated as before affording (VII). The reaction of (VII) with potassium phthalimide (VIII) gives the adduct (IX), which is cleaved with hydrazine yielding (2S,4S)-2-(aminomethyl)-1-(4-methoxybenzyloxycarbonyl)-4-(triphenylmeth ylsulfanyl)pyrrolidine (X). The condensation of (X) with N-(4-methoxybenzyl)sulfamoyl chloride (XI) by means of triethylamine affords the corresponding protected sulfamide (XII). Deprotection of the trityl group of (XII) by treatment with silver nitrate and pyridine affords compound (XIII) with a free SH group. The reaction of (XIII) with (1R,5S,6S)-2-(diphenoxyphosphoryloxy)-6-[1(R)-hydroxyethyl]-1-methyl-1-carba-2-penem-3-carboxylic acid 4-methoxybenzyl ester (XIV) by means of diisopropylethylamine yields the protected final product (XV), which is finally treated with AlCl3 in anisole to eliminate the protecting groups.

1 Iso, Y.; Motokawa, K.; Nishitani, Y.; Nishino, Y.; Irie, T.; A novel 1beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1beta-methylcarbapenems. J Antibiot 1996, 49, 2, 199.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14489 (2S,4R)-4-hydroxytetrahydro-1H-pyrrole-2-carboxylic acid; L-Hydroxyproline 51-35-4 C5H9NO3 详情 详情
(II) 15796 methyl (2S,4R)-4-hydroxytetrahydro-1H-pyrrole-2-carboxylate C6H11NO3 详情 详情
(III) 16080 1-(4-methoxybenzyl) 2-methyl (2S,4R)-4-hydroxytetrahydro-1H-pyrrole-1,2-dicarboxylate C15H19NO6 详情 详情
(IV) 16081 1-(4-methoxybenzyl) 2-methyl (2S,4R)-4-[(methylsulfonyl)oxy]tetrahydro-1H-pyrrole-1,2-dicarboxylate C16H21NO8S 详情 详情
(V) 16082 1-(4-methoxybenzyl) 2-methyl (2S,4S)-4-(tritylsulfanyl)-1,2-pyrrolidinedicarboxylate C34H33NO5S 详情 详情
(VI) 16083 4-methoxybenzyl (2S,4S)-2-(hydroxymethyl)-4-(tritylsulfanyl)-1-pyrrolidinecarboxylate C33H33NO4S 详情 详情
(VII) 16084 4-methoxybenzyl (2S,4S)-2-[[(methylsulfonyl)oxy]methyl]-4-(tritylsulfanyl)-1-pyrrolidinecarboxylate C34H35NO6S2 详情 详情
(VIII) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(IX) 16086 4-methoxybenzyl (2S,4S)-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-4-(tritylsulfanyl)-1-pyrrolidinecarboxylate C41H36N2O5S 详情 详情
(X) 16087 4-methoxybenzyl (2S,4S)-2-(aminomethyl)-4-(tritylsulfanyl)-1-pyrrolidinecarboxylate C33H34N2O3S 详情 详情
(XI) 16088 chloro([[(4-methoxybenzyl)oxy]carbonyl]amino)dioxo-lambda(6)-sulfane C9H10ClNO5S 详情 详情
(XII) 16089 4-methoxybenzyl (2S,4S)-2-([[([[(4-methoxybenzyl)oxy]carbonyl]amino)sulfonyl]amino]methyl)-4-(tritylsulfanyl)-1-pyrrolidinecarboxylate C42H43N3O8S2 详情 详情
(XIII) 16090 4-methoxybenzyl (2S,4S)-2-([[([[(4-methoxybenzyl)oxy]carbonyl]amino)sulfonyl]amino]methyl)-4-sulfanyl-1-pyrrolidinecarboxylate C23H29N3O8S2 详情 详情
(XIV) 16075 4-methoxybenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C30H30NO9P 详情 详情
(XV) 16092 4-methoxybenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[[(3S,5S)-1-[[(4-methoxybenzyl)oxy]carbonyl]-5-([[([[(4-methoxybenzyl)oxy]carbonyl]amino)sulfonyl]amino]methyl)pyrrolidinyl]sulfanyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C41H48N4O13S2 详情 详情

合成路线8

该中间体在本合成路线中的序号:(VIII)

2) The chiral intermediates the amine (I) and the acid (II) have been obtained as follows: 2a) The bromination of 1-tetralone (IV) with Br2 in methanol gives the 2-bromotetralone (V), which is treated with hydroxylamine yielding the corresponding oximae (VI). The isomerization of (V) with polyphosphoric acid (PPA) at 80 C affords the benzazepinone (VII), which is treated with potassium phthalimide (VIII) in DMF to give the corresponding phthalimido derivative (IX). The reaction of (IX) with tert-butyl bromoacetate (X) by means of potassium tert-butoxide in DMF yields the benzazepinoacetic ester (XI), which is treated with hot ethanolamine to eliminate the phthalimido group yielding racemic (I). Finally, this racemate is submitted to optical resolution with L-(+)-tartaric acid to afford the chiral (S)-intermediate (I).

1 Waldeck, H.; Höltje, D.; Messinger, J.; Antel, J.; Wurl, M.; Thormählen, D. (Kali-Chemie AG); Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivs., their preparation and their pharmaceutical compsns.. CA 2172354; EP 0733642; JP 1996269011; US 5677297 .
2 Rozsa, S.; Gy Papp, J.; Thormahlen, D.; Waldeck, H. (Solvay SA); Drugs for increasing gastrointestinal blood supply. DE 19638020; EP 0830863; JP 1998101565 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
rac-(I) 20728 tert-butyl 2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)acetate C16H22N2O3 详情 详情
(I) 20717 tert-butyl 2-[(3S)-3-amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetate C16H22N2O3 详情 详情
(IV) 20720 3,4-dihydro-1(2H)-naphthalenone 529-34-0 C10H10O 详情 详情
(V) 20721 2-bromo-3,4-dihydro-1(2H)-naphthalenone C10H9BrO 详情 详情
(VI) 20722 2-bromo-3,4-dihydro-1(2H)-naphthalenone oxime C10H10BrNO 详情 详情
(VII) 20723 3-bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one C10H10BrNO 详情 详情
(VIII) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(IX) 20725 2-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)-1H-isoindole-1,3(2H)-dione C18H14N2O3 详情 详情
(X) 17430 2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate 5292-43-3 C6H11BrO2 详情 详情
(XI) 20727 tert-butyl 2-[3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetate C25H26N2O5 详情 详情

合成路线9

该中间体在本合成路线中的序号:(VIII)

2a) The chiral intermediate amine (I) has been obtained as follows: The bromination of 1-tetralone (IV) with Br2 in methanol gives the 2-bromotetralone (V), which is treated with hydroxylamine yielding the corresponding oximae (VI). The isomerization of (V) with polyphosphoric acid (PPA) at 80 C affords the benzazepinone (VII), which is treated with potassium phthalimide (VIII) in DMF to give the corresponding phthalimido derivative (IX). The reaction of (IX) with tert-butyl bromoacetate (X) by means of potassium tert-butoxide in DMF yields the benzazepinoacetic ester (XI), which is treated with hot ethanolamine to eliminate the phthalimido group yielding racemic (I). Finally, this racemate is submitted to optical resolution with L-(+)-tartaric acid to afford the chiral (S)-intermediate (I).

1 Sorbera, L.A.; Leeson, P.A.; Castañer, J.; SLV-306. Drugs Fut 2002, 27, 1, 27.
2 Waldeck, H.; Höltje, D.; Messinger, J.; Antel, J.; Wurl, M.; Thormählen, D. (Kali-Chemie AG); Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivs., their preparation and their pharmaceutical compsns.. CA 2172354; EP 0733642; JP 1996269011; US 5677297 .
3 Rozsa, S.; Gy Papp, J.; Thormahlen, D.; Waldeck, H. (Solvay SA); Drugs for increasing gastrointestinal blood supply. DE 19638020; EP 0830863; JP 1998101565 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
rac-(I) 20728 tert-butyl 2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)acetate C16H22N2O3 详情 详情
(I) 20717 tert-butyl 2-[(3S)-3-amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetate C16H22N2O3 详情 详情
(IV) 20720 3,4-dihydro-1(2H)-naphthalenone 529-34-0 C10H10O 详情 详情
(V) 20721 2-bromo-3,4-dihydro-1(2H)-naphthalenone C10H9BrO 详情 详情
(VI) 20722 2-bromo-3,4-dihydro-1(2H)-naphthalenone oxime C10H10BrNO 详情 详情
(VII) 20723 3-bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one C10H10BrNO 详情 详情
(VIII) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(IX) 20725 2-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)-1H-isoindole-1,3(2H)-dione C18H14N2O3 详情 详情
(X) 17430 2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate 5292-43-3 C6H11BrO2 详情 详情
(XI) 20727 tert-butyl 2-[3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetate C25H26N2O5 详情 详情

合成路线10

该中间体在本合成路线中的序号:(I)

Alkylation of potassium phthalimide (I) with an excess of 1,8-dibromooctane (II) in refluxing acetone afforded N-(8-bromooctyl)phthalimide (III). This was condensed with 6-O-demethylgalanthamine (IV) in the presence of Et3N in boiling acetonitrile to give phthalimidooctyl compound (V). Finally, reaction with N-bromosuccinimide in the presence of azobisisobutyronitrile provided the iminium bromide.

1 Mary, A.; Renko, D.Z.; Guillou, C.; Thal, C.; Potent acetylcholinesterase inhibitors: Design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series. Bioorg Med Chem 1998, 6, 10, 1835.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(II) 18610 1,8-dibromooctane 4549-32-0 C8H16Br2 详情 详情
(III) 18611 2-(8-bromooctyl)-1H-isoindole-1,3(2H)-dione 17702-83-9 C16H20BrNO2 详情 详情
(IV) 18612 (6R,8aS)-3-methoxy-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol C16H19NO3 详情 详情
(V) 18613 2-[8-[(6R,8aS)-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11(12H)-yl]octyl]-1H-isoindole-1,3(2H)-dione C32H38N2O5 详情 详情

合成路线11

该中间体在本合成路线中的序号:(XIV)

After bromination of the methyl group of (XII) with N-bromosuccinimide in the presence of 2,2'-azobis(isobutyro-nitrile) to give (XIII), the aminomethyl derivative (XVI) was obtained by condensation with potassium phthalimide (XIV) in DMF and subsequent hydrazinolysis of the resulting (XV). Treatment with methanesulfonyl chloride and triethylamine then provided sulfonamide (XVII), and the ester function was finally hydrolyzed to the target carboxylic acid with NaOH in a mixture of H2O/MeOH/THF.

1 Cho, N.; Nara, Y.; Harada, M.; Sugo, T.; Masuda, Y.; Abe, A.; Kusumoto, K.; Itoh, Y.; Ohtaki, T.; Watanabe, T.; Furuya, S.; Thieno[2,3-d]pyrimidine-3-acetic acids a new class of nonpeptide endothelin receptor antagonists. Chem Pharm Bull 1998, 46, 11, 1724.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XII) 18320 ethyl 2-[6-[4-(methoxymethoxy)phenyl]-5-methyl-1-[2-(methylsulfanyl)benzyl]-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C27H28N2O6S2 详情 详情
(XIII) 18321 ethyl 2-[5-(bromomethyl)-6-[4-(methoxymethoxy)phenyl]-1-[2-(methylsulfanyl)benzyl]-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C27H27BrN2O6S2 详情 详情
(XIV) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(XV) 18323 ethyl 2-[5-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-6-[4-(methoxymethoxy)phenyl]-1-[2-(methylsulfanyl)benzyl]-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C35H31N3O8S2 详情 详情
(XVI) 18324 ethyl 2-[5-(aminomethyl)-6-[4-(methoxymethoxy)phenyl]-1-[2-(methylsulfanyl)benzyl]-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C27H29N3O6S2 详情 详情
(XVII) 18325 ethyl 2-[6-[4-(methoxymethoxy)phenyl]-1-[2-(methylsulfanyl)benzyl]-5-[[(methylsulfonyl)amino]methyl]-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C28H31N3O8S3 详情 详情

合成路线12

该中间体在本合成路线中的序号:(IV)

Condensation of epichlorohydrin (I) with N-benzylethanolamine (II) in the presence of sulfuric acid afforded the (chloromethyl)morpholine (III). Halogen displacement in (III) by potassium phthalimide (IV) provided the substituted phthalimide (V). Further hydrazinolysis of (V) furnished racemic (aminomethyl)morpholine (VI) (1). The desired (S) enantiomer (VII) was obtained by crystallization of (VI) as the dibenzoyl-D-tartaric acid salt, followed by liberation of the base with NaOH. Eschweiler-Clarke reductive methylation of (VII) with formaldehyde and formic acid produced the dimethylamino derivative (VIII). The N-benzyl groupof (VIII) was then cleaved by transfer hydrogenation in the presence of hydrazine and Pd/C yielding chiral morpholine (IX). Finally, coupling of this morpholine (IX) with the difluoroqyuinolone boron chelate (X) provided the title morpholino quinolone.

1 Sakurai, N.; Sano, M.; Hirayama, F.; Kuroda, T.; Uemori, S.; Moriguchi, A.; Yamamoto, K.; Ikeda, Y.; Kawakita, T.; Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents. Bioorg Med Chem Lett 1998, 8, 16, 2185.
2 Uemori, S.; Hirayama, F.; Moriguchi, A.; Sano, M.; Yokoyama, Y.; Ikeda, Y.; Miyoshi, M.; Sakurai, N.; Yamamoto, K.; Kawakita, T.; Synthesis and anti-Helicobacter pylori activity of Y-34867, a new 7-morpholinoquinolone. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-85.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10146 Epichlorohydrin; 2-(Chloromethyl)oxirane 106-89-8 C3H5ClO 详情 详情
(II) 25630 2-(benzylamino)-1-ethanol 104-63-2 C9H13NO 详情 详情
(III) 13396 4-Benzyl-2-(chloromethyl)morpholine C12H16ClNO 详情 详情
(IV) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(V) 13398 2-[(4-Benzyl-2-morpholinyl)methyl]-1H-isoindole-1,3(2H)-dione C20H20N2O3 详情 详情
(VI) 13399 (4-Benzyl-2-morpholinyl)methylamine; (4-Benzyl-2-morpholinyl)methanamine C12H18N2O 详情 详情
(VII) 25362 1,4,8,11-Tetraazacyclotetradecane 295-37-4 C10H24N4 详情 详情
(VIII) 25633 N-[[(2S)-4-benzylmorpholinyl]methyl]-N,N-dimethylamine C14H22N2O 详情 详情
(IX) 25634 N,N-dimethyl-N-[(2R)morpholinylmethyl]amine C7H16N2O 详情 详情
(X) 25635 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid diacetoxyboron complex C18H16BF2NO8 详情 详情

合成路线13

该中间体在本合成路线中的序号:(IV)

Lithiation of 1-(N-N-dimethylsulfamoyl)imidazole (I) followed by reaction with tert-butyldimethylsilyl chloride produced the 2-silyl protected imidazole (II). Further lithiation of (II) allowed the introduction of a bromohexyl group at position 5 upon treatment with 1,6-dibromohexane yielding (III). Bromide (III) was subsequently converted into primary amine (VI) through a Gabriel synthesis involving condensation with potassium phthalimide (IV) with concomitant desilylation, and then hydrazinolysis of the resulting alkylated phthalimide (V). Condensation of amine (VI) with naphthalene-2-sulfonyl chloride (VII) furnished sulfonamide (VIII). The sulfamoyl protecting group of (VIII) was finally removed by hydrolysis with HCl.

1 Tozer, M.J.; Kalindjian, B.; Pether, M.J.; Watt, G.F.; Shankley, N.P.; Harper, E.A.; From histamine to imidazolylalkyl-sulfonamides: The design of a novel series of histamine H3-receptor antagonists. Bioorg Med Chem Lett 1999, 9, 13, 1825.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
24786 1,6-dibromohexane 629-03-8 C6H12Br2 详情 详情
(I) 11036 N,N-Dimethyl-1H-imidazole-1-sulfonamide 78162-58-0 C5H9N3O2S 详情 详情
(II) 11037 2-[tert-Butyl(dimethyl)silyl]-N,N-dimethyl-1H-imidazole-1-sulfonamide C11H23N3O2SSi 详情 详情
(III) 27986 5-(6-bromohexyl)-2-[tert-butyl(dimethyl)silyl]-N,N-dimethyl-1H-imidazole-1-sulfonamide C17H34BrN3O2SSi 详情 详情
(IV) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(V) 27987 5-[6-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)hexyl]-N,N-dimethyl-1H-imidazole-1-sulfonamide C19H24N4O4S 详情 详情
(VI) 27988 5-(6-aminohexyl)-N,N-dimethyl-1H-imidazole-1-sulfonamide C11H22N4O2S 详情 详情
(VII) 27989 2-naphthalenesulfonyl chloride 93-11-8 C10H7ClO2S 详情 详情
(VIII) 27990 N,N-dimethyl-5-[6-[(2-naphthylsulfonyl)amino]hexyl]-1H-imidazole-1-sulfonamide C21H28N4O4S2 详情 详情

合成路线14

该中间体在本合成路线中的序号:(VII)

 

1 Kawahan H, Mori M, etal.2002. Preparation of 6-aminomethyl-6,11-dihydro-5H-dibenzo[b.e]azepine as intermediate for epinastine, hydrochloride,antiallergyagent. JP 2002308851
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 62393 2-benzylaniline; 2-benzylphenylamine 28059-64-5 C13H13N 详情 详情
(II) 66338 2-benzyl-N-(3-chloroprop-1-en-2-yl)aniline   C16H16ClN 详情 详情
(III) 62395 6-(chloromethyl)-11H-dibenzo[b,e]azepine 21535-44-4 C15H12ClN 详情 详情
(IV) 66339 2-((11H-dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione   C23H16N2O2 详情 详情
(V) 66340 6-(Phthalimidomethyl)-6,11-dihydro-5H-dibenz[b,e]azepine 143878-20-0 C23H18N2O2 详情 详情
(VI) 12465 6,11-Dihydro-5H-dibenzo[b,e]azepin-6-ylmethylamine; 6,11-Dihydro-5H-dibenzo[b,e]azepin-6-ylmethanamine C15H16N2 详情 详情
(VII) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情

合成路线15

该中间体在本合成路线中的序号: (IV)

 

1 Krishna Reddy P. 2005.A novel process for the preparation of linezolicl and related compounds. 2005099353[本专利为Symed Laboratories Ltd (IN)所有]
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(V) 66499 (S)-2-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)isoindoline-1,3-dione   C22H20FN3O5 详情 详情
(I) 17015 3-fluoro-4-morpholinophenylamine; 3-fluoro-4-morpholinoaniline; 3-fluoro-4-(4-morpholinyl)phenylamine; 3-Fluoro-4-(4-morpholinyl)benzeneamine 93246-53-8 C10H13FN2O 详情 详情
(II) 66497 (S)-1-chloro-3-((3-fluoro-4-morpholinophenyl)amino)propan-2-ol   C13H18ClFN2O2 详情 详情
(III) 66498 (S)-5-(chloromethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one   C14H16ClFN2O3 详情 详情

合成路线16

该中间体在本合成路线中的序号:(II)

 

1 Mohan Rao D.2006. Novel intermediates for linezolid and related compounds. W0 20066008754[本专利为Symed Laboratories Ltd (IN)所有]
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 66501 (S)-2-(3-((3-fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)isoindoline-1,3-dione   C21H22FN3O4 详情 详情
(V) 66502 (S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione   C11H9NO3 详情 详情
(I) 66497 (S)-1-chloro-3-((3-fluoro-4-morpholinophenyl)amino)propan-2-ol   C13H18ClFN2O2 详情 详情
(II) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(IV) 17015 3-fluoro-4-morpholinophenylamine; 3-fluoro-4-morpholinoaniline; 3-fluoro-4-(4-morpholinyl)phenylamine; 3-Fluoro-4-(4-morpholinyl)benzeneamine 93246-53-8 C10H13FN2O 详情 详情
(VII) 17021 (5S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)-1,3-oxazolan-2-one C14H18FN3O3 详情 详情
Extended Information